Wikipedia

Talk:Abcam

Latest comment: 5 years ago by Spintendo in topic Request edit
Learn more about this page

Lead para

edit
Latest comment: 7 years ago1 comment1 person in discussion

Everything I can find about this co suggests they're a (or even the) major supplier of materials and reagents to life-sciences researchers worldwide. The lead para makes them sound more like a social-media company. Which is correct?

This is what investing.com says about them, or more likely what they say about themselves.

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support

Compare this with the page lead!

Chrismorey (talk) 08:15, 5 November 2017 (UTC)Reply

Edit request

edit
Latest comment: 5 years ago2 comments2 people in discussion

Hello, I'm Patrick and work at Abcam. We'd like to make some changes to this page as it is now quite out of date and is missing and/or showing false information. In line with community guidelines, please see our requests below with references.

Extended content

About

Our "about section" and bio is quite out of date and doesn't truly reflect the business as it stands.

Information to be added or removed: Abcam has over 1,100 employees; Explanation of issue: our employee number is incorrect; References supporting change: [1]

Information to be added or removed: Abcam is a global supplier of research tools for the life sciences industry; Explanation of issue: our current description doesn't properly fit the business; References supporting change: [2]

Information to be added or removed: Abcam provides validated antibodies, reagents, and other tools to life science researchers which are essential in a wide range of fields including drug discovery, diagnostics and basic research; Explanation of issue: the areas we work in have expanded and the page does not address this; References supporting change: [3]

Acquisitions

As with any publicly traded company, these are important to investors and the market.

Information to be added or removed: Firefly is now known as FirePlex; Explanation of issue: this product has had a name change; References supporting change: [4]

Information to be added or removed: Abcam acquired Calico Biolabs in January 2019. Calico Biolabs is a developer of custom high-quality recombinant rabbit monoclonal antibodies for diagnostic and biopharmaceutical companies; Explanation of issue: this acquisition is not included on the page; References supporting change: [5]

Partnerships

These partnerships are important for investors and the life science community.

Information to be added or removed: Abcam collaborates with Molecular Devices to develop screening tools for the life sciences industry; Explanation of issue: this recent partnership is not referenced on the page; References supporting change: [6]

Information to be added or removed: Abcam Merck collaboration produces new PD-L1 antibody for Immuno-oncology research; Explanation of issue: this partnership is not referenced on the page; References supporting change: [7]

Information to be added or removed: Abcam and the Lou Lou Foundation collaborate to discover new tools to advance research for the development of therapeutics for CKL15 deficiency disorder; Explanation of issue: this partnership is not referenced on the page; References supporting change: [8]

Information to be added or removed: Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging; Explanation of issue: this partnership is not referenced on the page; References supporting change: [9]

Information to be added or removed: NanoString and Abcam enter commercial partnership to provide expanded menu of antibodies for GeoMx Digital Spatial Profiler; Explanation of issue: this partnership is not referenced on the page; References supporting change: [10]

Validation standards

These practices are very important to the life science community and there are a couple of important updates we've made that are not referenced on the page.

Information to be added or removed: In 2015, Abcam introduced knockout validation to address the industry need for higher quality antibodies; Explanation of issue: our standards have changed quite a bit in the time since this page was last updated, and this area is very important for the market and life science community; References supporting change: [11]

Financials

Since we are a publicly traded company it is vital that the market and the community are up to date with our financial results. The data on our page is very out of date.

Information to be added or removed: Abcam’s revenue in 2018 was £233.2m; Explanation of issue: our revenue is incredibly out of date on here, but we publish our results every year; References supporting change: [12]

Information to be added or removed: Abcam’s net income in 2018 was £62.2m; Explanation of issue: our net income is also out of date; References supporting change: [13]

References

  1. ^ https://www.cambridgeindependent.co.uk/business/inside-abcams-new-46million-headquarters-on-cambridge-biomedical-campus-9064030/
  2. ^ https://www.manufacturingchemist.com/news/article_page/Abcam_acquires_Calico_Biolabs/151262
  3. ^ https://www.fool.co.uk/investing/2018/09/10/should-i-pile-into-abcam-down-15-today/
  4. ^ https://www.genengnews.com/magazine/324/wisdom-of-the-antibody-crowd/
  5. ^ https://www.manufacturingchemist.com/news/article_page/Abcam_acquires_Calico_Biolabs/151262
  6. ^ https://www.fiercebiotech.com/cro/abcam-molecular-devices-join-forces-to-develop-immunoassays-for-researchers
  7. ^ https://www.pharmajournalist.com/pharma-news/abcam-merck-collaboration-produces-new-pd-l1-antibody-for-immuno-oncology-research/
  8. ^ http://www.pharmatimes.com/news/abcam_and_loulou_foundation_form_cdkl5_deficiency_disorder_partnership_1275867
  9. ^ https://www.biospace.com/article/abcam-collaborates-with-visikol-to-develop-new-tools-for-improved-tissue-clearing-and-3d-imaging/
  10. ^ https://instrumentbusinessoutlook.com/press-release/nanostring-abcam-enter-commercial-partnership-provide-expanded-menu-antibodies-geomx-digital-spatial-profiler/
  11. ^ https://www.biospace.com/article/releases/abcam-plc-raises-antibody-validation-standards-to-improve-quality-for-life-science-researchers-/
  12. ^ https://www.marketwatch.com/investing/stock/abczf/financials
  13. ^ https://www.marketwatch.com/investing/stock/abczf/financials

Abcamofficial (talk) 09:01, 2 September 2019 (UTC)Reply

Reply 02-SEP-2019

edit

   Edit request declined  
Your edit request was declined for two reasons:

  1. Text in the request was found to be insufficiently paraphrased from the source material. Submitted text ought to be written using an editor's own words and phrases.
  2. The citation style used in the edit request consists of bare URL's.[a] The citation style predominantly used by the Abcam article is Citation Style 1 (CS1). Any requested edit of yours which may be implemented will need to resemble the current style already in use in the article — in this case, CS1.[b]

In the extended section below titled Citation style, I have illustrated two examples: one showing how the edit request was submitted, and another showing how requests should be submitted in the future:

Citation style
Bare URL reference formatting:

The Sun's diameter is 864,337 miles,[1] while the Moon's diameter is 2,159 miles.[2] The Sun's temperature is 5,778 Kelvin.[3]

References

1. https://www.booksource.com
2. http://www.journalsource.com
3. http://www.websource.com

In the example above there are three URL's provided with the claim statements, but these URL's have not been placed using Citation Style 1, which is the style predominantly used by the Abcam article. Using this style, the WikiFormatted text should resemble the following:

Citation Style 1 formatting:

The Sun's diameter is 864,337 miles,<ref>{{cite book|last1=Sjöblad|first1=Tristan|title=The Sun|url=http://www.booksource.com|publisher=Academic Press|date=2019|page=1}}</ref> while the Moon's diameter is 2,159 miles.<ref>{{cite journal|last1=Harinath|first1=Paramjit|title=Size of the Moon|journal=Science|issue=78|volume=51|url=http://www.journalsource.com|date=2019|page=46}}</ref> The Sun's temperature is 5,778 Kelvin.<ref>{{cite web|last1=Uemura|first1=Shu|title=The Sun's Heat|url=http://www.websource.com|publisher=Academic Press|date=2019|page=2}}</ref>

Which displays as:

The Sun's diameter is 864,337 miles,[1] while the Moon's diameter is 2,159 miles.[2] The Sun's temperature is 5,778 Kelvin.[3]

References

  1. ^ Sjöblad, Tristan. The Sun. Academic Press, 2019, p. 1.
  2. ^ Harinath, Paramjit. (2019). "Size of the Moon", Science, 51(78):46.
  3. ^ Uemura, Shū. The Sun's Heat. Academic Press, 2019, p. 2.

In the example above the references have been formatted according to Citation Style 1, which shows the author, the source's name, date, etc., all information which is lost when only the links are provided. As Wikipedia is a volunteer project, edit requests such yours are generally expected to have this formatting done before the request is submitted for review.

Notes

  1. ^ The use of bare URLs as references is a style which is acceptable for use in Wikipedia. However, general practice dictates that the style already in use for an article be the one that is subsequently used for all future additions unless changed by editorial consensus.[1]
  2. ^ The fault for this formatting error may have originated with the automated prompts used by the edit request template, which asks for a COI editor to "supply the URL of any references used". While the resulting omission of information would not be the fault of the requesting COI editor, it nevertheless remains their responsibility to supply the references formatted in the style used by the article.

References

  1. ^ "WP:CITEVAR - Wikipedia:Citing sources". Wikipedia. 20 October 2018. Retrieved 22 October 2018. Guideline: It is normal practice to defer to the style used by the first major contributor or adopted by the consensus of editors already working on the page, unless a change in consensus has been achieved. If the article you are editing is already using a particular citation style, you should follow it.

Kindly resubmit the edit request below at your earliest convenience, taking care to ensure that it makes use of CS1 and contains words and phrases of your own making. If you have any questions about this formatting please don't hesitate to ask myself or another editor. Regards,  Spintendo  11:25, 2 September 2019 (UTC)Reply

Request edit

edit
Latest comment: 5 years ago2 comments2 people in discussion

Hello, it's Patrick again! Thanks so much for your feedback. I've had to create a new profile as the old one conflicted with wiki's rules. I've added CS1 referencing, however some the references did not have authors listed. I've also changed the paraphrasing from the sources as much as I could - it was quite hard to do this for some of the information (like a product name change or an acquisition or financial results), but I did what I could! he collaborations section was quite challenging. Do let me know if there's a way I can do this better. Hope this looks better so we can update the page. Thanks!

Extended content

About

Our "about section" and bio is quite out of date and doesn't truly reflect the business as it stands.

Information to be added or removed: Abcam has over 1,100 employees; Explanation of issue: our employee number is incorrect; References supporting change: [1]

Information to be added or removed: Abcam is a producer, distributor and seller of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery; Explanation of issue: our current description doesn't properly fit the business; References supporting change: [2]

Acquisitions

As with any publicly traded company, these are important to investors and the market.

Information to be added or removed: Firefly is now known as FirePlex; Explanation of issue: this product has had a name change; References supporting change: [3]

Information to be added or removed: Abcam acquired Calico Biolabs in January 2019. Calico Biolabs is a developer of custom high-quality recombinant rabbit monoclonal antibodies for diagnostic and biopharmaceutical companies; Explanation of issue: this acquisition is not included on the page; References supporting change: [4]

Partnerships

These partnerships are important for investors and the life science community.

Information to be added or removed: Abcam collaborated with Molecular Devices, supplier of bioanalytical measurement systems, to develop new high-sensitivity fluorescent enzyme-linked immunosorbent assay (ELISA) kits; Explanation of issue: this recent partnership is not referenced on the page; References supporting change: [5]

Information to be added or removed: Abcam Merck collaboration produces new PD-L1 antibody for Immuno-oncology research; Explanation of issue: this partnership is not referenced on the page; References supporting change: [6]

Information to be added or removed: Abcam and the Lou Lou Foundation collaborate to discover new tools to advance research for the development of therapeutics for CKL15 deficiency disorder; Explanation of issue: this partnership is not referenced on the page; References supporting change: [7]

Information to be added or removed: Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging; Explanation of issue: this partnership is not referenced on the page; References supporting change: [8]

Information to be added or removed: NanoString and Abcam enter commercial partnership to provide expanded menu of antibodies for GeoMx Digital Spatial Profiler; Explanation of issue: this partnership is not referenced on the page; References supporting change: [9]

Validation standards

These practices are very important to the life science community and there are a couple of important updates we've made that are not referenced on the page.

Information to be added or removed: In 2015, Abcam introduced knockout (KO) validation to serve the critical industry need for specific and consistent antibodies; Explanation of issue: our standards have changed quite a bit in the time since this page was last updated, and this area is very important for the market and life science community; References supporting change: [10]

Financials

Since we are a publicly traded company it is vital that the market and the community are up to date with our financial results. The data on our page is very out of date. This is primarily for the right hand company bio box that shows them.

Information to be added or removed: Abcam’s revenue in 2018 was £233.2m; Explanation of issue: our revenue is incredibly out of date on here, but we publish our results every year; References supporting change: [11]

Information to be added or removed: Abcam’s net income in 2018 was £62.2m; Explanation of issue: our net income is also out of date; References supporting change: [12]

References

  1. ^ Brackley, Paul. "Inside Abcam's new £46million headquarters on Cambridge Biomedical Campus". Cambridge Independent. Iliffe Media Publishing Ltd. Retrieved 16 September 2019.
  2. ^ "Abcam acquires Calico Biolabs". Manufacturing Chemist. HCPi Media. Retrieved 16 September 2019.
  3. ^ Dutton, Gail. "Wisdom of the Antibody Crowd". GEN. Mary Ann Liebert, Inc. Retrieved 16 September 2019.
  4. ^ "Abcam acquires Calico Biolabs". Manufacturing Chemist. HPCi Media. Retrieved 16 September 2019.
  5. ^ Liu, Angus. "Abcam, Molecular Devices join forces to develop immunoassays for researchers". Fierce Biotech. Questex LLC. Retrieved 16 September 2019.
  6. ^ "Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Pharma Journalist. Kellen Media. Retrieved 16 September 2019.
  7. ^ Smith, Anna. "Abcam and Loulou Foundation form CDKL5 deficiency disorder partnership". PharmaTimes Online. PharmaTimes Media Ltd. Retrieved 16 September 2019.
  8. ^ "Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging". Biospace. Biospace. Retrieved 16 September 2019.
  9. ^ "NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler". Instrument Business Outlook. IBO. Retrieved 16 September 2019.
  10. ^ "Abcam plc Raises Antibody Validation Standards To Improve Quality For Life Science Researchers". Biospace. Biospace. Retrieved 16 September 2019.
  11. ^ "Abcam PLC". Market Watch. MarketWatch Inc. Retrieved 16 September 2019.
  12. ^ "Abcam PLC". Market Watch. MarketWatch Inc. Retrieved 16 September 2019.

Patrickfromabcam (talk) 08:57, 16 September 2019 (UTC)Reply

Reply 2-OCT-2019

edit

   Clarification requested  

  • Thank you for providing the properly formatted references, it's much appreciated.
  • To expedite your request, please provide the following information:
  1. Please state each specific desired change in the form of verbatim statements which can then be added to the article (if approved) by the reviewer.
  2. The exact location where the desired claims are to be placed should be given.
  3. Exact, verbatim descriptions of any text or references to be removed should also be given.[1]
  4. Reasons should be provided for each change (Please note: These have already been provided by the COI editor).
  • In the section of text below titled Sample edit request, the four required items are shown as an example:
Sample edit request

1. Please remove the third sentence from the second paragraph of the Sun section:

"The Sun's diameter is estimated to be approximately 25 miles in length."


2. Please add the following claim as the third sentence of the second paragraph of the Sun section:

"The Sun's diameter is estimated to be approximately 864,337 miles in length."


3. Using as the reference:[a]

Paramjit Harinath (2019). The Sun. Academic Press. p. 1.The Sun&rft.pages=1&rft.pub=Academic Press&rft.date=2019&rft.au=Paramjit Harinath&rfr_id=info:sid/en.wikipedia.org:Talk:Abcam" class="Z3988">


4. Reason for change being made:

"The previously given diameter was incorrect."

Notes

  1. ^ The formatting of the references as they stand after the last revision by the COI editor should not be changed, as they are now correctly formatted. These references should be added to the proposed verbatim text, which the COI editor still needs to provide.

References

  1. ^ "Template:Request edit". Wikipedia. 15 September 2018. Instructions for Submitters: Describe the requested changes in detail. This includes the exact proposed wording of the new material, the exact proposed location for it, and an explicit description of any wording to be removed, including removal for any substitution.
  • Kindly open a new edit request at your earliest convenience when ready to proceed with the two needed items missing from the request (the verbatim text of additions and deletions).[a] Thank you!


Regards,  Spintendo  16:36, 2 October 2019 (UTC)Reply

Notes

  1. ^ In the case of the About and Validation standards sections, it appears that verbatim text has been provided. However, in the Partnerships and Acquisitions sections, the verbatim text has not been provided (i.e., "Abcam Merck collaboration produces new PD-L1 antibody for Immuno-oncology research" and "Firefly is now known as FirePlex" which both read like announcements, when the text should ideally be placed as prose).

Request edit

edit
Latest comment: 5 years ago2 comments2 people in discussion

Thanks for responding! OK, I’ve amended the request below to suit your recommendations.

Extended content

Change of first line summary. Location: under page header, first lines of paragraph copy on the entire page.

Please remove “Abcam is a life-science e-commerce company which facilitates public customer feedback on products using reviews and ratings submitted by customers. Since 2011, through acquisition, the company has moved into direct production of biotechnological products.[2]” and replace with “Abcam is a producer, distributor and seller of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery. In 2015, Abcam introduced knockout validation to address the industry need for higher quality antibodies” [1] and [2]

Change of net income section in right hand side bio box. Thank you for changing the employee number and revenue number, but the net income section still needs changing.

Please remove "£49.6m (2015)[1]" and add £62.2m (2019) [3]

These changes are to be made in the Acquisitions section.

Information to be added: After the Firefly section (starts On 20 January, Abcam announced the acquisition of Firefly...) please add "Firefly was rebranded to FirePlex in 2016."; Explanation of issue: this product has had a name change; References supporting change: [4]

Information to be added: Underneath as a new paragraph after the AxioMx section within the Acquisitions section, please add "Abcam acquired Calico Biolabs in January 2019. Calico Biolabs is a developer of custom high-quality recombinant rabbit monoclonal antibodies for diagnostic and biopharmaceutical companies; Explanation of issue: this acquisition is not included on the page; References supporting change: [5]

Addition of partnerships. Nothing to remove here, but can we have a new section underneath the Acquisitions section titled Partnerships. Then list out the following sentences in the same style as the Acquisitions section, as individual statements.

Information to be added: Abcam collaborated with Molecular Devices, supplier of bioanalytical measurement systems, to develop new high-sensitivity fluorescent enzyme-linked immunosorbent assay (ELISA) kits; Explanation of issue: this recent partnership is not referenced on the page; References supporting change: [6]

Information to be added: Abcam Merck collaboration produces new PD-L1 antibody for Immuno-oncology research; Explanation of issue: this partnership is not referenced on the page; References supporting change: [7]

Information to be added: Abcam and the Lou Lou Foundation collaborate to discover new tools to advance research for the development of therapeutics for CKL15 deficiency disorder; Explanation of issue: this partnership is not referenced on the page; References supporting change: [8]

Information to be added or removed: Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging; Explanation of issue: this partnership is not referenced on the page; References supporting change: [9]

Information to be added: NanoString and Abcam enter commercial partnership to provide expanded menu of antibodies for GeoMx Digital Spatial Profiler; Explanation of issue: this partnership is not referenced on the page; References supporting change: [10]

References

  1. ^ "Abcam acquires Calico Biolabs". Manufacturing Chemist. HCPi Media. Retrieved 16 September 2019.
  2. ^ "Abcam plc Raises Antibody Validation Standards To Improve Quality For Life Science Researchers". Biospace. Biospace. Retrieved 16 September 2019.
  3. ^ "Abcam PLC". Market Watch. MarketWatch Inc. Retrieved 16 September 2019.
  4. ^ Dutton, Gail. "Wisdom of the Antibody Crowd". GEN. Mary Ann Liebert, Inc. Retrieved 16 September 2019.
  5. ^ "Abcam acquires Calico Biolabs". Manufacturing Chemist. HPCi Media. Retrieved 16 September 2019.
  6. ^ Liu, Angus. "Abcam, Molecular Devices join forces to develop immunoassays for researchers". Fierce Biotech. Questex LLC. Retrieved 16 September 2019.
  7. ^ "Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Pharma Journalist. Kellen Media. Retrieved 16 September 2019.
  8. ^ Smith, Anna. "Abcam and Loulou Foundation form CDKL5 deficiency disorder partnership". PharmaTimes Online. PharmaTimes Media Ltd. Retrieved 16 September 2019.
  9. ^ "Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging". Biospace. Biospace. Retrieved 16 September 2019.
  10. ^ "NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler". Instrument Business Outlook. IBO. Retrieved 16 September 2019.

I hope these changes are ok for you.

Patrickfromabcam (talk) 10:06, 3 October 2019 (UTC)Reply

Reply 3-OCT-2019

edit

Below you will see where proposals from your request have been quoted with reviewer decisions and feedback inserted underneath, either accepting, declining or otherwise commenting upon your proposal(s). Please read the enclosed notes within the proposal review section below for information on each request.  Spintendo  14:39, 3 October 2019 (UTC)Reply

Proposal review 3-OCT-2019

Abcam is a producer, distributor and seller of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery. In 2015, Abcam introduced knockout validation to address the industry need for higher quality antibodies.
  Declined.[note 1]


Net income: £62.2m (2019)
  Approved.Cite error: There are <ref> tags on this page without content in them (see the help page).


Firefly was rebranded to FirePlex in 2016.
  Approved.Cite error: There are <ref> tags on this page without content in them (see the help page).


Abcam acquired Calico Biolabs in January 2019.
  Approved.Cite error: There are <ref> tags on this page without content in them (see the help page).


Calico Biolabs is a developer of custom high-quality recombinant rabbit monoclonal antibodies for diagnostic and biopharmaceutical companies
  Declined.[note 2]


Abcam collaborated with Molecular Devices, supplier of bioanalytical measurement systems, to develop new high-sensitivity fluorescent enzyme-linked immunosorbent assay (ELISA) kits
 Clarification needed.[note 3]


Abcam Merck collaboration produces new PD-L1 antibody for Immuno-oncology research
  Declined.[note 4]


Abcam and the Lou Lou Foundation collaborate to discover new tools to advance research for the development of therapeutics for CKL15 deficiency disorder
  Declined.[note 5]


Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging
  Declined.[note 6]


NanoString and Abcam enter commercial partnership to provide expanded menu of antibodies for GeoMx Digital Spatial Profiler
  Declined.[note 7]


___________

  1. ^ These claims discuss how the company's products "enable life scientists to analyse components of living cells at the molecular level" which is promotional of these products. Any mention of the company's products should describe what the products are used for in a generalized manner, rather than describing what the tools do for the scientists who use them. For example, a manufacturer of doors may describe themselves and their products in either a generalized way (as a "manufacturer of doors") or in a promotional way (as a "creator and seller of high-quality hand-crafted wood items which enable the user to enter and exit many different types of structures.") The less-promotional description mentions only the product, while the promotional one describes how the customer uses the product. The former version should be used in Wikipedia, especially in lead sections. This part of the proposed text also contains subjective prose (e.g., "..which is essential in a wide range of fields including drug discovery.". Claims about what is or is not essential should not be placed using Wikipedia's voice unless a body of sources are provided which verify the purported essential-nature of the item.
  2. ^ This information is germane to an article on Calico Biolabs.
  3. ^ This claim does not state when it occurred.
  4. ^ This claim is written as an announcement in headline style. Proposed claims ought to be written in prose.
  5. ^ Ibid.
  6. ^ Ibid.
  7. ^ Ibid.

Request edit

edit
Latest comment: 5 years ago2 comments2 people in discussion

I really appreciate the changes you've made! Thank you for the advice around other areas of it. Please see below some changes for the page, hopefully in line with the feedback you gave.

Extended content

Change of first line summary. Location: under page header, first lines of paragraph copy on the entire page.

Please remove “Abcam is a life-science e-commerce company which facilitates public customer feedback on products using reviews and ratings submitted by customers. Since 2011, through acquisition, the company has moved into direct production of biotechnological products.[2]” and replace with “Abcam is a producer, distributor and seller of protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level in a wide range of fields including drug discovery.” [1] and [2]

Change of net income section in right hand side bio box. Thank you for changing the employee number and revenue number, but the net income section date still needs changing.

Please remove "2015" and add "2018" [3]

I try to rework the partnerships part so it is less 'statementy'. Thanks so much!

References

  1. ^ "Abcam acquires Calico Biolabs". Manufacturing Chemist. HCPi Media. Retrieved 16 September 2019.
  2. ^ "Abcam plc Raises Antibody Validation Standards To Improve Quality For Life Science Researchers". Biospace. Biospace. Retrieved 16 September 2019.
  3. ^ "Abcam PLC". Market Watch. MarketWatch Inc. Retrieved 16 September 2019.

Patrickfromabcam (talk) 14:03, 4 October 2019 (UTC)Reply

Reply 8-OCT-2019

edit

   Edit request implemented    Spintendo  13:24, 8 October 2019 (UTC)Reply

Add topic
Retrieved from "https://en.wikipedia.org/w/index.php?title=Talk:Abcam&oldid=1204427367"